321
Views
2
CrossRef citations to date
0
Altmetric
REVIEW

How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 1587-1604 | Received 24 Mar 2023, Accepted 22 May 2023, Published online: 05 Jun 2023

References

  • Hom MM, Nguyen AL, Bielory L. Allergic conjunctivitis and dry eye syndrome. Ann Allergy Asthma Immunol. 2012;108:163–166.
  • Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90–98. doi:10.1016/j.ajo.2017.06.033
  • Leonardi A, Castegnaro A, Valerio AL, Lazzarini D. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study. Curr Opin Allergy Clin Immunol. 2015;15:482–488. doi:10.1097/ACI.0000000000000204
  • Leonardi A, Luigi R, Salami M, Salami E. Allergy and dry eye disease. Ocular Immunol Inflamm. 2021;29:1168–1176.
  • Clayton JA. Dry eye. N Engl J Med. 2018;378(23):2212–2223. doi:10.1056/NEJMra1407936
  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283.
  • Palmares J, Delgado L, Cidade M, Quadrado MJ, Filipe HP. Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life. Eur J Ophthalmol. 2010;20(2):257–264. doi:10.1177/112067211002000201
  • Uchino M, Uchino Y, Dogru M, et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157(2):294–300. doi:10.1016/j.ajo.2013.10.014
  • Grubbs JR, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality-of-life measures in dry eye questionnaires. Cornea. 2014;33(2):215–218. doi:10.1097/ICO.0000000000000038
  • Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799–806. doi:10.1016/j.ajo.2013.12.023
  • Schiffman RM, Walt JG, Jacobsen F, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412–1419. doi:10.1016/S0161-6420(03)00462-7
  • Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17:38–56. doi:10.1097/00003226-199801000-00007
  • Suárez-Cortés T, Merino-Inda N, Benitez-Del-Castillo JM. Tear and ocular surface disease biomarkers: a diagnostic and clinical perspective for ocular allergies and dry eye disease. Exp Eye Res. 2022;221:109121. doi:10.1016/j.exer.2022.109121
  • Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol. 2015;9:1719–1730. doi:10.2147/OPTH.S89700
  • Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23(3):272–285. doi:10.1097/00003226-200404000-00010
  • Sambursky R, Davitt WF, Friedberg M, Tauber S. Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease. Cornea. 2014;33:812–818. doi:10.1097/ICO.0000000000000175
  • Nichols KK, Nichols JJ, Mitchell GL, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762–770.5. doi:10.1097/01.ico.0000133997.07144.9e
  • Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444–457. doi:10.1016/j.ajo.2004.04.052
  • Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;47(2):198–205, e1. doi:10.1016/j.ajo.2008.08.032
  • Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328:584. doi:10.1056/NEJM199302253280817
  • Abusharha AA, Pearce EI. The effect of low humidity on the human tear film. Cornea. 2013;32(4):429–434. doi:10.1097/ICO.0b013e31826671ab
  • Ishida R, Kojima T, Dogru M, et al. The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol. 2005;139:253–258. doi:10.1016/j.ajo.2004.08.075
  • Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, et al. Conjunctival allergen provocation test: guidelines for daily practice. Allergy Eur J Allergy Clin Immunol. 2017;72(1):43–54.
  • Galor A, Levitt RC, Felix ER, et al. Neuropathic ocular pain: an important yet under evaluated feature of dry eye. Eye. 2015;29:301–312. doi:10.1038/eye.2014.263
  • Galor A, Zlotcavitch L, Walter SD, et al. Eye symptom severity and persistence are associated with symptoms of neuropathic pain. Br J Ophthalmol. 2015;99:665–668. doi:10.1136/bjophthalmol-2014-306057
  • Rosenthal P, Borsook D. The corneal pain system. Part I: the missing piece of the dry eye puzzle. Ocul Surf. 2012;10:2–14. doi:10.1016/j.jtos.2012.01.002
  • Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438–510. doi:10.1016/j.jtos.2017.05.011
  • Willcox MDP, Argueso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15:366–403. doi:10.1016/j.jtos.2017.03.006
  • Tiffany JM. The normal tear film. Dev Ophthalmol. 2008;41:1–20.
  • Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47:4309–4315. doi:10.1167/iovs.05-1504
  • Kari O, Määttä M, Tervahartiala T, et al. Tear fluid concentration of MMP-8 is elevated in non-allergic eosinophilic conjunctivitis and correlates with conjunctival inflammatory cell infiltration. Graefes Arch Clin Exp Ophthalmol. 2009;247:681–686. doi:10.1007/s00417-009-1042-5
  • Gumus K, Cavanagh DH. The role of inflammation and anti-inflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol. 2009;3:57–67.
  • Paranjpe V, Tan J, Nguyen J, et al. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition. Ocul Surf. 2019;2:318–326. doi:10.1016/j.jtos.2018.12.006
  • Galor A, Moein HR, Lee C, et al. Neuropathic pain and dry eye. Ocul Surf. 2018;16:31–44. doi:10.1016/j.jtos.2017.10.001
  • Ohashi Y, Ishida R, Kojima T, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol. 2003;136:291–299. doi:10.1016/S0002-9394(03)00203-4
  • Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292.
  • Tei M, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. Invest Ophthalmol Vis Sci. 2000;41:82–88.
  • Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100:300–306. doi:10.1136/bjophthalmol-2015-307415
  • Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg D. The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye. Clin Ophthalmol. 2017;11:1423–1430. doi:10.2147/OPTH.S120159
  • Ambrósio R Jr, Tervo T, Wilson SE. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg. 2008;24(2):396–407. doi:10.3928/1081597X-20080401-14
  • Pinto-Fraga J, Enríquez-de-salamanca A, Calonge M, et al. Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a Phase III clinical trial. Ocul Surf. 2018;16:368–376. doi:10.1016/j.jtos.2018.05.001
  • Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol. 1988;106:570–574. doi:10.1016/0002-9394(88)90587-9
  • Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;9:161–166. doi:10.1111/aos.12012
  • Fujishima H, Toda I, Shimazaki J, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol. 1996;80(11):994–997. doi:10.1136/bjo.80.11.994
  • Serin D, Karsloglu S, Kyan A, Alagoz G. A simple approach to the repeatability of the Schirmer test without anesthesia: eyes open or closed? Cornea. 2007;26:903–906. doi:10.1097/ICO.0b013e3180950083
  • Yamaguchi T. Inflammatory response in dry eye. Invest. Ophthalmol Vis Sci. 2018;59:192–199. doi:10.1167/iovs.17-23651
  • Nichols KK, Mitchell GL, Zadnik K. Performance and Repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea. 2002;21(6):578–583. doi:10.1097/00003226-200208000-00009
  • Mangione CM. Development of the 25-list-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119(7):1050–1058. doi:10.1001/archopht.119.7.1050
  • Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren’s syndrome-related dry eye. Health Qual Life Outcomes. 2004;2:44. doi:10.1186/1477-7525-2-44
  • Ngo W, Situ P, Keir N, et al. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea. 2013;32(9):1204–1210. doi:10.1097/ICO.0b013e318294b0c0
  • Schiffman RM. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615–621. doi:10.1001/archopht.118.5.615
  • Unlü C, Güney E, Akçay Bİ, et al. Comparison of ocular-surface disease index questionnaire, tear film break-up time, and Schirmer tests for the evaluation of the tear film in computer users with and without dry-eye symptomatology. Clin Ophthalmol. 2012;6:1303–1306. doi:10.2147/OPTH.S33588
  • Van Der Meid KR, Su SP, Ward KW, Zhang JG. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest Ophthalmol Vis Sci. 2012;53:1512–1518. doi:10.1167/iovs.11-7627
  • Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33(2):55–60. doi:10.1016/j.clae.2009.12.010
  • Begley CG, Caffery B, Chalmers RL, et al. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002;21:664–670. doi:10.1097/00003226-200210000-00007
  • Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci. 2008;85:E692–E699. doi:10.1097/OPX.0b013e318181ae36
  • Abelson MB, Ousler GW, Nally LA, et al. Alternative reference values for tear film breakup time in normal and dry eye populations. Adv Exp Med Biol. 2002;506:1121–1125.
  • Tsubota K, Nakamori K. Effects of ocular surface area and blink rate on tear dynamics. Arch Ophthalmol. 1995;113:155–158. doi:10.1001/archopht.1995.01100020037025
  • Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Investig Ophthalmol Vis Sci. 2011;52:1994–2005. doi:10.1167/iovs.10-6997e
  • Bourcier T, Acosta MC, Borderie V, et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci. 2005;46:2341–2345.8. doi:10.1167/iovs.04-1426
  • Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15:404–437. doi:10.1016/j.jtos.2017.05.002
  • Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991;32:2272–2280.
  • Shine WE, Silvany R, McCulley JP. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci. 1993;34:2291–2296.
  • Cox SM, Nichols KK, Nichols JJ. Agreement between automated and traditional measures of tear film breakup. Optom Vis Sci. 2015;92:e257–e63. doi:10.1097/OPX.0000000000000648
  • Goto T, Zheng X, Okamoto S, Ohashi Y. Tear film stability analysis system: introducing a new application for video keratography. Cornea. 2004;23:S65e70. doi:10.1097/01.ico.0000136685.88489.70
  • Cedarstaff TH, Tomlinson A. Human tear volume, quality, and evaporation: a comparison of Schirmer, tear break-up time and resistance hygrometry techniques. Ophthalmic Physiol Opt. 1983;3:239–245. doi:10.1111/j.1475-1313.1983.tb00609.x
  • Pflugfelder SC, Tseng SC, Yoshino K, et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with Rose Bengal staining in patients with ocular irritation. Ophthalmology. 1997;104:223–235. doi:10.1016/S0161-6420(97)30330-3
  • Yokoi N, Georgiev GA, Kato H, et al. Classification of fluorescein breakup patterns: a novel method of differential diagnosis for dry eye. Am J Ophthalmol. 2017;180:72–85. doi:10.1016/j.ajo.2017.05.022
  • Javadi MA, Feizi S. Dry eye syndrome. J Ophthalmic Vis Res. 2011;6(3):192–198.
  • Tsubota K, Kaido M, Yagi Y, Fujihara T, Shimmura S. Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol. 1999;83(1):89–91. doi:10.1136/bjo.83.1.89
  • Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology. 1980;87:920–930. doi:10.1016/S0161-6420(80)35143-9
  • Versura P, Frigato M, Cellini M, et al. Diagnostic performance of tear function tests in Sjogren’s syndrome patients. Eye. 2007;21:229–237.
  • Bitton E, Wittich W. Influence of eye position on the Schirmer tear test. Cont Lens Anterior Eye. 2014;37(4):257–261.
  • Li N, Deng XG, He MF. Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye. Int J Ophthalmol. 2012;5:478–481. doi:10.3980/j.issn.2222-3959.2012.04.14
  • Vashisht S, Singh S. Evaluation of phenol red thread test versus Schirmer test in dry eyes: a comparative study. Int J Appl Basic Med Res. 2011;1(1):40–42. doi:10.4103/2229-516X.81979
  • Prabhasawat P, Tseng SC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol. 1998;82:666–675. doi:10.1136/bjo.82.6.666
  • de Paive CS, Pflugfelder SC. Tear clearance implication for ocular surface health. Exp Eye Res. 2004;78(3):395–397. doi:10.1016/j.exer.2003.08.003
  • Xu KP, Yagi Y, Toda I, Tsubota K. Tear function index: a new measure of dry eye. Arch Ophthalmol. 1995;113:84–88. doi:10.1001/archopht.1995.01100010086025
  • Savini G, Barboni P, Zanini M. Tear meniscus evaluation by optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2006;37(37):112–118. doi:10.3928/1542-8877-20060301-06
  • Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res. 1996;15(6):653–661. doi:10.3109/02713689609008906
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–650. doi:10.1097/00003226-200310000-00008
  • Bron AJ, Argueso P, Irkec M, Bright FV. Clinical staining of the ocular surface: mechanisms and interpretations. Prog Retin Eye Res. 2015;44:36–61. doi:10.1016/j.preteyeres.2014.10.001
  • Khan-Lim D, Berry M. Still confused about Rose Bengal? Curr Eye Res. 2004;29:311–317. doi:10.1080/02713680490516864
  • Caffery BE, Josephson JE. Corneal staining after sequential instillations of fluorescein over 30 days. Optom Vis Sci. 1991;68:467–469. doi:10.1097/00006324-199106000-00011
  • Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:6125–6130. doi:10.1167/iovs.10-5390
  • Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44(11):4753–4761. doi:10.1167/iovs.03-0270
  • Kim J, Foulks GN. Evaluation of the effect of lissamine green and Rose Bengal on human corneal epithelial cells. Cornea. 1999;18(3):328–332. doi:10.1097/00003226-199905000-00015
  • Feenstra RP, Tseng SC. What is actually stained by Rose Bengal? Arch Ophthalmol. 1992;110:984–993. doi:10.1001/archopht.1992.01080190090035
  • Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: Rose Bengal versus lissamine green. Cornea. 2009;28(7):732–734. doi:10.1097/ICO.0b013e3181930c03
  • Watanabe S, Tanaka M. Rose Bengal staining and expression of mucin-like glycoprotein in cornea epithelium. Invest Ophthal Vis Sci. 1996;37:S357.
  • Savini G, Prabhawasat P, Kojima T, et al. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2:31–55. doi:10.2147/OPTH.S1496
  • Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–2049. doi:10.1167/iovs.10-6997f
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
  • Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10(4):277–285. doi:10.1097/00003226-199107000-00001
  • Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye. 1991;5(Pt 4):395–411. doi:10.1038/eye.1991.65
  • Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea. 1991;10(4):286–290. doi:10.1097/00003226-199107000-00002
  • Blackie CA, Korb DR. The diurnal secretory characteristics of individual meibomian glands. Cornea. 2010;29(1):34–38. doi:10.1097/ICO.0b013e3181ac9fd0
  • Calonge M, Diebold Y, Sáez V, et al. Impression cytology of the ocular surface: a review. Exp Eye Res. 2004;78:457–472. doi:10.1016/j.exer.2003.09.009
  • Smith J, Nichols KK, Baldwin EK. Current patterns in the use of diagnostic tests in dry eye evaluation. Cornea. 2008;27:656–662. doi:10.1097/01.ico.0000611384.81547.8d
  • Zang S, Cui Y, Cui Y, Fei W. Meibomian gland dropout in Sjogren’s syndrome and non-Sjogren’s dry eye patients. Eye. 2018;32:1681–1687. doi:10.1038/s41433-018-0149-5
  • Enriquez-de-salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.
  • Montes-Mico R, Caliz A, Alio JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg. 2004;20(3):243–247. doi:10.3928/1081-597X-20040501-08
  • Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability analysis using videokeratography. Am J Ophthalmol. 2003;135(5):607–612. doi:10.1016/S0002-9394(02)02221-3
  • King-Smith PE, Kimball SH, Nichols JJ. Tear film interferometry and corneal surface roughness. Invest Ophthalmol Vis Sci. 2014;55:2614–2618. doi:10.1167/iovs.14-14076
  • Doane MG. An instrument for in vivo tear film interferometry. OptomVis Sci. 1989;66(6):383–388. doi:10.1097/00006324-198906000-00008
  • Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for meibomian gland dysfunction. Cornea. 2013;32:1549–1553. doi:10.1097/ICO.0b013e3182a7f3e1
  • Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009;28(7):789–794. doi:10.1097/ICO.0b013e318191b870
  • Jung JW, Park SY, Kim JS, Kim EK, Seo KY, Kim TI. Analysis of factors associated with the tear film lipid layer thickness in normal eyes and patients with dry eye syndrome. Invest Ophthalmol Vis Sci. 2016;57:4076–4083. doi:10.1167/iovs.16-19251
  • Jackson MA. A systematic approach to dry eye using lipiflow treatment. US Ophthalmic Rev. 2014;7:104–108. doi:10.17925/USOR.2014.07.02.104
  • Ngo W, Srinivasan S, Schulze M, Jones L. Repeatability of grading meibomian gland dropout using two infrared systems. Optom Vis Sci. 2014;91:658–667. doi:10.1097/OPX.0000000000000279
  • Koh S, Maeda N, Hirohara Y, et al. Serial measurements of higher-order aberrations after blinking in normal subjects. Invest Ophthalmol Vis Sci. 2006;47:3318. doi:10.1167/iovs.06-0018
  • Lin YY, Carrel H, Wang IJ, et al. Effect of tear film break-up on higher order aberrations of the anterior cornea in normal, dry, and post-LASIK eyes. J Refract Surg. 2005;21(5):S525–9. doi:10.3928/1081-597X-20050901-21
  • Liang Q, Pan Z, Zhou M, et al. Evaluation of optical coherence tomography meibography in patients with obstructive meibomian gland dysfunction. Cornea. 2015;34:1193–1199. doi:10.1097/ICO.0000000000000563
  • Tung CI, Perin AF, Gumus K, Pflugfelder SC. Tear meniscus dimensions in tear dysfunction and their correlation with clinical parameters. Am J Ophthalmol. 2014;157:301.e1. doi:10.1016/j.ajo.2013.09.024
  • Nguyen P, Huang D, Li Y, et al. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea. 2012;31(6):680–685. doi:10.1097/ICO.0b013e3182261577
  • Chan TCY, Wan KH, Shih KC, Jhanji V. Advances in dry eye imaging: the present and beyond. Br J Ophthalmol. 2018;102(3):295–301. doi:10.1136/bjophthalmol-2017-310759
  • Villani E, Baudouin C, Efron N, et al. In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res. 2014;39(39):213–231. doi:10.3109/02713683.2013.842592
  • Bron AJ, Tomlinson A, Foulks GN, et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12:S1–S31 . doi:10.1016/j.jtos.2014.02.002
  • Versura P, Nanni P, Bavelloni A, et al. Tear proteomics in evaporative dry eye disease. Eye. 2010;24:1396–1402. doi:10.1038/eye.2010.7
  • Mathews PM, Karakus S, Agrawal D, Hindman HB, Ramulu PY, Akpek EK. Tear osmolarity and correlation with ocular surface parameters in patients with dry eye. Cornea. 2017;36:1352–1357. doi:10.1097/ICO.0000000000001364
  • Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792–8 e1. doi:10.1016/j.ajo.2010.10.032
  • Keech A, Senchyna M, Jones L. Impact of time between collection and collection method on human tear fluid osmolarity. Curr Eye Res. 2013;38(38):428–436. doi:10.3109/02713683.2013.763987
  • Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? Am J Ophthalmol. 2014;157(1):69–77.e2. doi:10.1016/j.ajo.2013.07.019
  • Szalai E, Berta A, Szekanecz Z, Szûcs G, L M Jr. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea. 2012;31:867–871. doi:10.1097/ICO.0b013e3182532047
  • Tashbayev B, Utheim TP, Utheim ØA, et al. Utility of tear osmolarity measurement in diagnosis of dry eye disease. Sci Rep. 2020;10:5542. doi:10.1038/s41598-020-62583-x
  • Bunya VY, Fuerst NM, Pistilli M, et al. Variability of tear osmolarity in patients with dry eye. JAMA Ophthalmol. 2015;133(6):662–667. doi:10.1001/jamaophthalmol.2015.0429
  • Baenninger PB, Voegeli S, Bachmann LM, et al. Variability of tear osmolarity measurements with a point-of-care system in healthy subjects-systematic review. Cornea. 2018;37(7):938–945. doi:10.1097/ICO.0000000000001562
  • Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol. 2010;45:129–138.
  • Li M, Du C, Zhu D, Shen M, Cui L, Wang J. Daytime variations of tear osmolarity and tear meniscus volume. Eye Contact Lens. 2012;38(5):282–287. doi:10.1097/ICL.0b013e31825fed57
  • Suzuki S, Goto E, Dogru M, et al. Tear film lipid layer alterations in allergic conjunctivitis. Cornea. 2006;25:277–280. doi:10.1097/01.ico.0000178277.29010.bc
  • Sánchez L, Calvo M, Brock JH. Biological role of lactoferrin. Arch Dis Child. 1992;67(5):657–661. doi:10.1136/adc.67.5.657
  • Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009;8(8):4889–4905. doi:10.1021/pr900686s
  • Narayanan S, Redfern RL, Miller WL, Nichols KK, McDermott AM. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013;11:75–92. doi:10.1016/j.jtos.2012.12.002
  • Seal DV, McGill JI, Mackie IA, Liakos GM, Jacobs P, Goulding NJ. Bacteriology and tear protein profiles of the dry eye. Br J Ophthalmol. 1986;70:122–125. doi:10.1136/bjo.70.2.122
  • Boukes RJ, Boonstra A, Breebaart AC, et al. Analysis of human tear protein profiles using high performance liquid chromatography (HPLC). Doc Ophthalmol. 1987;67:105–113. doi:10.1007/BF00142704
  • Grus FH, Podust VN, Bruns K, et al. SELDI-TOF-MS protein chip array profiling of tears from patients with dry eye. Investig Ophthalmol Vis Sci. 2005;46:863. doi:10.1167/iovs.04-0448
  • D’Souza S, Tong L. Practical issues concerning tear protein assays in dry eye. Eye Vis. 2014;1:6. doi:10.1186/s40662-014-0006-y
  • Mackie IA, Seal DV. Confirmatory tests for the dry eye of Sjogren’s syndrome. Scand J Rheumatol Suppl. 1986;61:220–223.
  • Gillette TE, Allansmith MR. Lactoferrin in human ocular tissues. Am J Ophthalmol. 1980;90:30–37. doi:10.1016/S0002-9394(14)75074-3
  • Kijlstra A, Jeurissen SH, Koning KM. Lactoferrin levels in normal human tears. Br J Ophthalmol. 1983;67(3):199–202. doi:10.1136/bjo.67.3.199
  • Ono M, Fujita H, Goto E, Naka H, Walcott B, Tsubota K. Decreased tear lactoferrin secretion by cellular dysfunction. Invest Ophthalmol Vis Sci. 1998;39:S1100.
  • Sonobe H, Ogawa Y, Yamada K, et al. A novel and innovative paper-based analytical device for assessing tear lactoferrin of dry eye patients. Ocul Surf. 2019;17:160–166. doi:10.1016/j.jtos.2018.11.001
  • Danjo Y, Lee M, Horimoto K, et al. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol. 1994;72:433–437. doi:10.1111/j.1755-3768.1994.tb02791.x
  • Glasson MJ, Stapleton F, Keay L, et al. Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. investig. Ophthalmol Vis Sci. 2003;44:5116–5124. doi:10.1167/iovs.03-0685
  • Yamada K, Takaki S, Komuro N, Suzuki K, Citterio D. An antibody-free microfluidic paper-based analytical device for the determination of tear fluid lactoferrin by fluorescence sensitization of Tb3+. Analyst. 2014;139:1637–1643. doi:10.1039/c3an01926h
  • Kiratli H, Irkeç M, Orhan M. Tear lactoferrin levels in chronic meibomitis associated with acne rosacea. Eur J Ophthalmol. 2000;10:11–14.
  • Li K, Liu X, Chen Z, Huang Q, Wu K. Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis. Mol Vis. 2010;16:2084–2091.
  • Chiva A. Electrophoresis of tear proteins as a new diagnostic tool for two high risk groups for dry eye: computer users and contact lens wearers. J Med Life. 2011;154:228–233.
  • Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990;31:1119–1126.
  • Fukuda M, Wang HF. Dry eye and closed eye tears. Cornea. 2000;19:S44–8. doi:10.1097/00003226-200005001-00009
  • Da Dalt S, Moncada A, Priori R, Valesini G, Pivetti-Pezzi P. The lactoferrin tear test in the diagnosis of Sjogren’s syndrome. Eur J Ophthalmol. 1996;6:284–286. doi:10.1177/112067219600600311
  • Wang HF, Fukuda M, Shimomura Y. Diagnosis of dry eye. Semin Ophthalmol. 2005;20:53–62. doi:10.1080/08820530590931115
  • Ponzini E, Scotti L, Grandori R, Tavazzi S, Zambon A. Lactoferrin concentration in human tears and ocular diseases: a meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(12):9. doi:10.1167/iovs.61.12.9
  • Flanagan JL, Willcox MD. Role of lactoferrin in the tear film. Biochimie. 2009;91(1):35–43. doi:10.1016/j.biochi.2008.07.007
  • Reese V, Youngbar PR. The effect of punctal occlusion on tear lactoferrin in aqueous deficient dry eye patients. Adv Exp Med Biol. 2002;506:1269–1271.
  • Williams DL. A comparative approach to topical cyclosporine therapy. Eye. 1997;11(11):453–464. doi:10.1038/eye.1997.126
  • Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009;50:3203–3209. doi:10.1167/iovs.08-2476
  • Aragona P, Aguennouz M, Rania L, et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology. 2015;122:62–71. doi:10.1016/j.ophtha.2014.07.048
  • Sakimoto T, Ohnishi T, Ishimori A. Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients. Graefes Arch Clin Exp Ophthalmol. 2014;252:1451–1456. doi:10.1007/s00417-014-2708-1
  • Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2013;54(13):8285–8291. doi:10.1167/iovs.13-12235
  • Kaufman HE. The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea. 2013;32:211–216. doi:10.1097/ICO.0b013e3182541e9a
  • Sambursky R, Davitt WF 3rd, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131:24–28. doi:10.1001/jamaophthalmol.2013.561
  • Bang SP, Son MJ, Kim H, Lee YH, Jun JH. In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay. Sci Rep. 2020;10(1):15126. doi:10.1038/s41598-020-71977-w
  • Lanza NL, Valenzuela F, Perez VL, Galor A. The matrix metalloproteinase 9 point-of-care test in dry eye. Ocul Surf. 2016;14:189–195. doi:10.1016/j.jtos.2015.10.004
  • McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry. 2009;80(10):555–566. doi:10.1016/j.optm.2009.02.010
  • Pflugfelder SC. Anti-inflammatory therapy for dry eye. Am J Ophthalmol. 2004;137(2):337–342. doi:10.1016/j.ajo.2003.10.036
  • Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631–639. doi:10.1016/S0161-6420(99)00176-1
  • Park JY, Kim BG, Kim JS, Hwang JH. Matrix metalloproteinase 9 point-of-care immunoassay result predicts response to topical cyclosporine treatment in dry eye disease. Transl Vis Sci Technol. 2018;7:31. doi:10.1167/tvst.7.5.31
  • Sambursky R. Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. Clin Ophthalmol. 2016;10:2337–2343. doi:10.2147/OPTH.S121256
  • Dupuis P, Prokopich CL, Hynes A, Kim H. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol. 2020;6:1–18.
  • Shoji J. Ocular allergy test and biomarkers on the ocular surface: clinical test for evaluating the ocular surface condition in allergic conjunctival diseases. Allergol Int. 2020;69:496–504. doi:10.1016/j.alit.2020.05.003
  • Leonardi A, Lazzarini D, Bortolotti M, Piliego F, Midena E, Fregona I. Corneal confocal microscopy in patients with vernal keratoconjunctivitis. Ophthalmology. 2012;119(3):509–515. doi:10.1016/j.ophtha.2011.09.018
  • Nomura K, Takamura E. Tear IgE concentrations in allergic conjunctivitis. Eye. 1998;12(12):296–298. doi:10.1038/eye.1998.68
  • Mimura T, Usui T, Mori M, et al. Relationship between total tear and serum IgE in allergic conjunctivitis. Int Arch Allergy Immunol. 2011;154:349–352. doi:10.1159/000321828
  • Inada N, Shoji J, Kato H, Kiely S, Mulyanto SM, Sawa M. Clinical evaluation of total IgE in tears of patients with allergic conjunctivitis disease using a novel application of the immunochromatography method. Allergol Int. 2009;58(4):585–589. doi:10.2332/allergolint.09-OA-0101
  • Aalders-Deenstra V, Kok PT, Bruynzeel PL. Measurement of total IgE antibody levels in lacrimal fluid of patients suffering from atopic and non-atopic eye disorders. Evidence for local IgE production in atopic eye disorders? Br J Ophthalmol. 1985;69(5):380–384. doi:10.1136/bjo.69.5.380
  • Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology. 1995;102:302–309. doi:10.1016/S0161-6420(95)31024-X
  • Onguchi T, Dogru M, Okada N, et al. The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings. Am J Ophthalmol. 2006;141:569–571. doi:10.1016/j.ajo.2005.09.032
  • Dogru M, Asano-Kato N, Tanaka M, et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res. 2005;30:897–908. doi:10.1080/02713680500196715
  • Lobefalo L, D’Antonio E, Colangelo L, et al. Dry eye in allergic conjunctivitis: role of inflammatory infiltrate. Int J Immunopathol Pharmacol. 1999;12:133–137. doi:10.1177/205873929901200304
  • Berdy GJ, Hedqvist B. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management. Acta Ophthalmol Scand. 2000;230:32–37. doi:10.1034/j.1600-0420.2000.078s230032.x
  • Gipson IK, Argüeso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003;231:1–49.
  • Jumblatt MM, McKenzie RW, Jumblatt JE. MUC5AC mucin is a component of the human precorneal tear film. Investig Ophthalmol Vis Sci. 1999;40:43–49.
  • Zhang J, Yan X, Li H. Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye. Cornea. 2013;32:928–932. doi:10.1097/ICO.0b013e3182801622
  • Aydin E, Gokhale M, Azizoglu S, Suphioglu C. To see or not to see: a systematic review of the importance of human ocular surface cytokine biosignatures in ocular allergy. Cells. 2019;8:620. doi:10.3390/cells8060620
  • Leonardi A, Doan S, Fauquert JL, et al. Diagnostic tools in ocular allergy. Allergy. 2017;72:1485–1498. doi:10.1111/all.13178
  • Bielory L, Delgado L, Katelaris CH, Leonardi A, Rosario N, Vichyanoud P. ICON: diagnosis and management of allergic conjunctivitis. Ann Allergy Asthma Immunol. 2020;124:118–134. doi:10.1016/j.anai.2019.11.014
  • Tsubota K, Takamura E, Hasegawa T, Kobayashi T. Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis. Cornea. 1991;10:525–531. doi:10.1097/00003226-199111000-00011
  • Wakamatsu TH, Satake Y, Igarashi A, et al. IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis. Br J Ophthalmol. 2012;96:581–586. doi:10.1136/bjophthalmol-2011-300143
  • Kari O, Salo OP, Björkstén F, Backman A. Allergic conjunctivitis, total and specific IgE in the tear fluid. Acta Ophthalmol. 1985;63:97–99. doi:10.1111/j.1755-3768.1985.tb05224.x
  • Mimura T, Usui T, Yamagami S, Miyai T, Amano S. Relationship between total tear IgE and severity of acute seasonal allergic conjunctivitis. Curr Eye Res. 2012;37(10):864–870. doi:10.3109/02713683.2012.689069
  • Mimura T, Usui T, Yamagami S, Miyai T, Amano S. Relationship between total tear IgE and specific serum IgE in autumnal allergic conjunctivitis. Cornea. 2013;32(1):14–19. doi:10.1097/ICO.0b013e318253214b
  • Bao J, Tian L, Meng Y, et al. Clinical and translational allergy. Clin Transl Allergy. 2022;12:e12139. doi:10.1002/clt2.12139
  • Insler MS, Lim JM, Queng JT, et al. Tear and serum IgE concentrations by Tandem-R IgE immunoradiometric assay in allergic patients. Ophthalmology. 1987;94(8):945–948. doi:10.1016/S0161-6420(87)33355-X